|
TMEM48 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.4186208591459E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87900028869592E-10 |
| Normal-vs-Stage2 |
1.04550000001868E-06 |
| Normal-vs-Stage3 |
3.83330034381402E-10 |
| Normal-vs-Stage4 |
1.45099999793175E-08 |
| Stage1-vs-Stage2 |
6.994200E-01 |
| Stage1-vs-Stage3 |
3.157600E-01 |
| Stage1-vs-Stage4 |
2.573000E-01 |
| Stage2-vs-Stage3 |
7.466800E-01 |
| Stage2-vs-Stage4 |
5.575200E-01 |
| Stage3-vs-Stage4 |
7.260400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.12340170288894E-11 |
| Normal-vs-AfricanAmerican |
3.191600E-04 |
| Normal-vs-Asian |
1.46530000022516E-07 |
| Caucasian-vs-AfricanAmerican |
8.100200E-01 |
| Caucasian-vs-Asian |
3.880600E-01 |
| AfricanAmerican-vs-Asian |
4.255400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88430049341548E-10 |
| Normal-vs-Female |
1.27590049636694E-10 |
| Male-vs-Female |
2.300200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.83079998225833E-09 |
| Normal-vs-Age(41-60Yrs) |
2.72470934703506E-12 |
| Normal-vs-Age(61-80Yrs) |
1.57359999475304E-08 |
| Normal-vs-Age(81-100Yrs) |
9.375800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.047200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.716800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.664200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.171400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.109600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.945000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.292200E-01 |
| Classical-VS-Follicular |
2.600000E-03 |
| Classical-VS-Other |
9.620400E-02 |
| Classical-VS-Normal |
1.08700004552986E-09 |
| Tall-VS-Follicular |
3.705200E-01 |
| Tall-VS-Other |
2.541000E-01 |
| Tall-VS-Normal |
1.65255999999836E-05 |
| Follicular-VS-Other |
5.113800E-01 |
| Follicular-VS-Normal |
2.13929984838046E-11 |
| Other-VS-Normal |
6.233800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2467028237827E-11 |
| Normal-vs-N1 |
2.74529998733897E-09 |
| N0-vs-N1 |
1.808220E-01 |
|
|
